IMMODULON THERAPEUTICS LIMITED
LONDON

Hellopages » City of London » City of London » EC2M 5QQ
Company number 06223291
Status Active
Incorporation Date 23 April 2007
Company Type Private Limited Company
Address 475 SALISBURY HOUSE, LONDON WALL, LONDON, EC2M 5QQ
Home Country United Kingdom
Nature of Business 72190 - Other research and experimental development on natural sciences and engineering, 86900 - Other human health activities
Phone, email, etc

Since the company registration seventy-seven events have happened. The last three records are Total exemption small company accounts made up to 30 April 2016; Termination of appointment of John Michael Grange as a director on 11 October 2016; Statement of capital following an allotment of shares on 30 September 2016 GBP 101,979 . The most likely internet sites of IMMODULON THERAPEUTICS LIMITED are www.immodulontherapeutics.co.uk, and www.immodulon-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eighteen years and ten months. The distance to to Battersea Park Rail Station is 3.8 miles; to Brondesbury Park Rail Station is 5.5 miles; to Beckenham Hill Rail Station is 7.1 miles; to Bickley Rail Station is 9.9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Immodulon Therapeutics Limited is a Private Limited Company. The company registration number is 06223291. Immodulon Therapeutics Limited has been working since 23 April 2007. The present status of the company is Active. The registered address of Immodulon Therapeutics Limited is 475 Salisbury House London Wall London Ec2m 5qq. . GUIMAREY, Ilda Manuela is a Secretary of the company. AKLE, Charles Assad is a Director of the company. BOLTON, Anthony John is a Director of the company. KOHLI, Ulrich is a Director of the company. MACKENZIE-SMITH, Hugo Thomas Torquil is a Director of the company. MUDAN, Satvinder Singh is a Director of the company. ROBERTSON, Simon Manwaring, Sir is a Director of the company. SHANNON, James Samuel Small, Dr is a Director of the company. Secretary GRANGE, John Michael, Professor has been resigned. Secretary ROBERTS, Madeline Luisa has been resigned. Nominee Secretary CHALFEN SECRETARIES LIMITED has been resigned. Director DALGLEISH, Angus George, Dr has been resigned. Director GRANGE, John Michael, Professor has been resigned. Director STANFORD, John Lawson, Dr has been resigned. Nominee Director CHALFEN NOMINEES LIMITED has been resigned. The company operates in "Other research and experimental development on natural sciences and engineering".


Current Directors

Secretary
GUIMAREY, Ilda Manuela
Appointed Date: 09 November 2015

Director
AKLE, Charles Assad
Appointed Date: 23 April 2007
73 years old

Director
BOLTON, Anthony John
Appointed Date: 31 March 2015
75 years old

Director
KOHLI, Ulrich
Appointed Date: 16 November 2007
83 years old

Director
MACKENZIE-SMITH, Hugo Thomas Torquil
Appointed Date: 01 October 2009
53 years old

Director
MUDAN, Satvinder Singh
Appointed Date: 23 April 2007
64 years old

Director
ROBERTSON, Simon Manwaring, Sir
Appointed Date: 20 May 2015
84 years old

Director
SHANNON, James Samuel Small, Dr
Appointed Date: 03 August 2015
69 years old

Resigned Directors

Secretary
GRANGE, John Michael, Professor
Resigned: 20 May 2015
Appointed Date: 23 April 2007

Secretary
ROBERTS, Madeline Luisa
Resigned: 09 November 2015
Appointed Date: 20 May 2015

Nominee Secretary
CHALFEN SECRETARIES LIMITED
Resigned: 23 April 2007
Appointed Date: 23 April 2007

Director
DALGLEISH, Angus George, Dr
Resigned: 01 February 2009
Appointed Date: 23 April 2007
75 years old

Director
GRANGE, John Michael, Professor
Resigned: 11 October 2016
Appointed Date: 17 June 2015
82 years old

Director
STANFORD, John Lawson, Dr
Resigned: 23 March 2009
Appointed Date: 23 April 2007
87 years old

Nominee Director
CHALFEN NOMINEES LIMITED
Resigned: 23 April 2007
Appointed Date: 23 April 2007

IMMODULON THERAPEUTICS LIMITED Events

27 Jan 2017
Total exemption small company accounts made up to 30 April 2016
15 Nov 2016
Termination of appointment of John Michael Grange as a director on 11 October 2016
02 Nov 2016
Statement of capital following an allotment of shares on 30 September 2016
  • GBP 101,979

26 Jul 2016
Statement of capital following an allotment of shares on 14 July 2016
  • GBP 101,479.000000

15 Jun 2016
Statement of capital following an allotment of shares on 31 May 2016
  • GBP 101,031

...
... and 67 more events
25 Apr 2007
New director appointed
25 Apr 2007
New director appointed
25 Apr 2007
Secretary resigned
25 Apr 2007
Director resigned
23 Apr 2007
Incorporation